EF
CL icon

Empirical Finance’s Colgate-Palmolive CL Stock Holding History

Empirical Finance’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
29,035
+936
+3% +$81.9K 0.11% 159
2026
Q1 		$2.39M Sell
28,099
-56
-0.2% -$4.99K 0.11% 166
2025
Q4 		$2.22M Sell
28,155
-1,253
-4% -$98.2K 0.11% 158
2025
Q3 		$2.35M Buy
29,408
+279
+1% +$23.8K 0.11% 161
2025
Q2 		$2.65M Buy
29,129
+182
+0.6% +$16.6K 0.14% 144
2025
Q1 		$2.71M Buy
28,947
+500
+2% +$44.8K 0.16% 115
2024
Q4 		$2.59M Sell
28,447
-398
-1% -$38K 0.15% 120
2024
Q3 		$2.99M Buy
28,845
+632
+2% +$64.4K 0.17% 108
2024
Q2 		$2.74M Sell
28,213
-2,116
-7% -$195K 0.17% 112
2024
Q1 		$2.73M Buy
30,329
+996
+3% +$84.4K 0.17% 119
2023
Q4 		$2.34M Buy
29,333
+187
+0.6% +$14.1K 0.16% 123
2023
Q3 		$2.07M Buy
29,146
+2,766
+10% +$207K 0.15% 128
2023
Q2 		$2.03M Buy
26,380
+2,838
+12% +$220K 0.16% 125
2023
Q1 		$1.77M Buy
23,542
+1,273
+6% +$94.7K 0.17% 126
2022
Q4 		$1.75M Buy
22,269
+1,679
+8% +$126K 0.18% 120
2022
Q3 		$1.45M Buy
20,590
+3,330
+19% +$261K 0.17% 123
2022
Q2 		$1.38M Buy
17,260
+914
+6% +$71.5K 0.18% 113
2022
Q1 		$1.24M Buy
16,346
+1,772
+12% +$140K 0.14% 134
2021
Q4 		$1.24M Buy
14,574
+3,858
+36% +$301K 0.15% 126
2021
Q3 		$810K Buy
10,716
+591
+6% +$46.9K 0.12% 169
2021
Q2 		$824K Buy
10,125
+1,440
+17% +$118K 0.13% 181
2021
Q1 		$743K Hold
8,685
– – 0.13% 163
2020
Q4 		$743K Buy
8,685
+1,520
+21% +$126K 0.13% 163
2020
Q3 		$553K Buy
7,165
+1,480
+26% +$113K 0.12% 163
2020
Q2 		$416K Buy
5,685
+702
+14% +$49.9K 0.11% 159
2020
Q1 		$331K Buy
4,983
+1,765
+55% +$124K 0.1% 154
2019
Q4 		$222K Buy
+3,218
New +$219K 0.05% 195
2017
Q1 		– Sell
-404
Closed -$27K – 174
2016
Q4 		$27K Buy
+404
New +$27.7K 0.02% 160

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Empirical Finance's CL Position: Q2 2026 in Review

Empirical Finance increased its Colgate-Palmolive (CL) stake by 3.3% in Q2 2026, buying an estimated $81.9K and bringing the position to 29,035 shares worth $2.66M. The position accounts for 0.11% of the portfolio, ranked #159.

Empirical Finance first reported a position in CL in Q4 2016 and has held it in 28 quarters since. The position peaked at $2.99M in Q3 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Empirical Finance held 29,035 shares of Colgate-Palmolive worth $2.66M as of Q2 2026.
  • Empirical Finance bought 936 Colgate-Palmolive shares in Q2 2026, an estimated $81.9K.
  • Colgate-Palmolive made up 0.11% of Empirical Finance's portfolio in Q2 2026, its #159 holding.
  • Empirical Finance first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 28 quarters since.
  • Empirical Finance's Colgate-Palmolive position peaked at $2.99M in Q3 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.